Prognostic value of non-sustained ventricular tachycardias after acute myocardial infarction in the thrombolytic era: importance of combination with frequent ventricular premature beats

Z Kardiol. 2003 Feb;92(2):164-72. doi: 10.1007/s00392-003-0890-y.

Abstract

Purpose: of this study was to re-evaluate the association between ventricular arrhythmias and long-term mortality after acute myocardial infarction (AMI) in the thrombolytic era.

Methods: MITRA (maximal individual therapy in patients with AMI) is a multicenter registry of 54 hospitals in Germany investigating patients with AMI.

Results: 2420 patients received Holter ECG. Positive Holter ECG was defined: > or =10 ventricular premature beats (VPB)/h, or > or =4 couplets/d, or > or =1 non-sustained ventricular tachycardia (nsusVT)/d, or their combination. Mortality rates (median 17 months) were 6.5% without ventricular arrhythmias, with > or =10 VPB/h 15.2% and with the combination of > or =10 VPB/h plus either > or =4 couplets/d or > or =1 nsusVT/d 23.4%. In multivariate analysis, none of the ventricular arrhythmias alone correlated with mortality. There was a significant association between mortality and the combination of > or =10 VPB/h plus > or =4 couplets/d (OR 2.3) or > or =10 VPB/h plus > or =1 nsusVT/d (OR 2.8).

Conclusion: Non-sustained VTs are only associated with poor prognosis if combined with frequent VPBs.

Publication types

  • Evaluation Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Aspirin / therapeutic use
  • Cause of Death
  • Drug Therapy, Combination
  • Electrocardiography, Ambulatory
  • Female
  • Follow-Up Studies
  • Germany
  • Heart Failure / diagnosis
  • Heart Failure / mortality
  • Heart Failure / physiopathology
  • Humans
  • Male
  • Multivariate Analysis
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / physiopathology
  • Myocardial Reperfusion Injury / diagnosis*
  • Myocardial Reperfusion Injury / mortality
  • Myocardial Reperfusion Injury / physiopathology
  • Prognosis
  • Prospective Studies
  • Registries
  • Survival Rate
  • Tachycardia, Ventricular / diagnosis*
  • Tachycardia, Ventricular / mortality
  • Tachycardia, Ventricular / physiopathology
  • Thrombolytic Therapy*
  • Treatment Outcome
  • Ventricular Premature Complexes / diagnosis*
  • Ventricular Premature Complexes / mortality
  • Ventricular Premature Complexes / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Aspirin